Chester County News and Community Website
PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) said it submitted an Orphan Drug Designation application to the U.S. Food and Drug Administration for SkinJect (D-MNA) to treat basal cell …
Medicus Pharma Submits Orphan Drug Application for SkinJect Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration last week rolled out a sweeping slate of technology, enforcement, and approval actions that touch everything from artificial intelligence inside the …
FDA Bets Big On AI, Animal-Free Testing And High-Tech Cancer Cures Read More
WASHINGTON, D.C. — A seismic shift in pediatric medical care has arrived with the FDA’s approval of Ryoncil (remestemcel-L-rknd), a revolutionary therapy aimed at tackling the devastating condition known as steroid-refractory …
FDA Approves Groundbreaking Cell Therapy for Life-Threatening Pediatric Disease Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received orphan medicinal product designation from the European Medicines Agency (EMA) for OCU410ST, a promising treatment for ABCA4-associated retinopathies including Stargardt disease, …
Ocugen Secures EMA Orphan Designation for OCU410ST, Advancing Stargardt Disease Treatment Read More